| 溶解性 | DMSO: >5 mg/mL |
| 存贮条件 | 储存温度2-8℃ |
| 应用 | An AChR α4β2 partial agonist.Varenicline tartrate has been used to investigate its effect on sensorimotor gating in rats under prepulse inhibition (PPI). It is suitable for use as a reference standard in capillary isotachophoresis (ITP) coupled on-line with capillary zone electrophoresis (CZE) for the quantification of varenicline metabolite in urine samples. It is also suitable for use for testing its effect on locomotor and nonlocomotor behavioral deficits in rats. |
| 生化机理 | arenicline Tartrate is an AChR α4β2 partial agonist with a Ki value of 0.06 nM.Varenicline tartrate is a partial α4β2 nicotinic receptor agonist and α7 full agonist. Varenicline competitively binds to α4β2 receptors and partially stimulates without creating a full nicotine effect, while simultaneoudly blocking the ability of nicotine to bind to the receptors. Varenicline thus blocks the ability of nicotine to activate α4β2 receptors and stimulate the central nervous mesolimbic dopamine system, believed to be the neuronal mechanism underlying reinforcement and reward experienced upon smoking. |
| 别名 | 酒石酸伐尼克兰;7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine tartrateChampix;CP 526555-18;Champix tartrate;Chantix tartrate |
酒石酸伐仑克林
Varenicline tartrate （订货以英文为准）
编号：V120183
CAS号：375815-87-5
分子式：C17H19N3O6
分子量：361.35
| 产品名称 | Varenicline tartrate |
| 中文名称 | 酒石酸伐仑克林 |
| CAS号 | 375815-87-5 |
| 分子式（M.F.） | C17H19N3O6 |
| 分子量（M.W.） | 361.35 |
| 储存条件 | 2-8°C储存;充氩 |
| Reaxys-RN | 2410901 |
| 标识符号 | https://www.aladdin-e.com/images/ghs/ghs06.jpg,https://www.aladdin-e.com/images/ghs/ghs08.jpg,https://www.aladdin-e.com/images/ghs/ghs09.jpg |
| 信号词 | Danger |
| 危害声明 | H301,H331,H373,H410 |
| 警示性声明 | P261,P273,P301+P310,P311,P501 |
| RTECS | EK7713840 |
| WGK德国 | 3 |
| 风险声明 (欧洲) | R23/25; R33; R50/53 |
| 安全声明（欧洲） | S20/21; S28; S45; S60; S61 |
| 危害码（欧洲） | T N |
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 278.90
M292692-50ml-1mL
¥ 132.50
725301-1块
¥ 968.00
S0035S-200次
党沛 
